Yunnan Baiyao Group Co Ltd Class A 000538
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥52.93
- Day Range
- CN¥52.68–53.94
- 52-Week Range
- CN¥46.29–57.66
- Bid/Ask
- CN¥53.70 / CN¥53.71
- Shares Outstanding
- 1.78B
- Market Cap
- CN¥95.83B
- Volume/Avg
- 11M / 9M
Key Statistics
- Price/Earnings (Normalized)
- 18.90
- Price/Sales
- 2.24
- Dividend Yield (Trailing)
- 2.95%
- Dividend Yield (Forward)
- 2.95%
- Dividend Payment Schedule
- Apr
- Total Yield
- 2.95%
Company Profile
Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which include herbal products, daily health products, raw medicine, drug classics, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 9,286
- Website
- https://www.yunnanbaiyao.com.cn
Valuation
|
Metric
|
000538
|
|---|---|
Price/Earnings (Normalized) | 18.90 |
Price/Book Value | 2.38 |
Price/Sales | 2.24 |
Price/Cash Flow | 19.12 |
Price/Earnings
000538
Financial Strength
|
Metric
|
000538
|
|---|---|
Quick Ratio | 1.92 |
Current Ratio | 2.51 |
Interest Coverage | 277.04 |
Quick Ratio
000538
Profitability
|
Metric
|
000538
|
|---|---|
Return on Assets (Normalized) | 9.02% |
Return on Equity (Normalized) | 12.17% |
Return on Invested Capital (Normalized) | 12.00% |
Return on Assets
000538
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|@VTq??g | LOCK|TpSm | $74B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|WJcC?Rn% | LOCK|%DXPv | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|xwVvhN | LOCK|QG< | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|nnpW???H | LOCK|cBc | $33B | |||
| Viatris Inc
VTRS
| LOCK|@@BhxFg | LOCK|W%& | $22B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|fHqM%^j | LOCK|!Y | $12B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?QF | LOCK|N> | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|M$#xdP< | LOCK|m% | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|%k##HCv | LOCK|Fl&vh | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|WdCN%@ | LOCK|?<? | $2B |
United States